Ephrin-dependent and -independent activities of the receptor tyrosine kinase EphB4

被引：0
|
作者：
Yang, Nai-Ying Michelle
Noren Hooten, Nikki
Pasquale, Elena B.
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-3115
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3115
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Imidazo[1,2-a]pyrazine diaryl ureas: Inhibitors of the receptor tyrosine kinase EphB4
    Mitchell, Scott A.
    Danca, Mihaela Diana
    Blomgren, Peter A.
    Darrow, James W.
    Currie, Kevin S.
    Kropf, Jeffrey E.
    Lee, Seung H.
    Gallion, Steven L.
    Xiong, Jin-Ming
    Pippin, Douglas A.
    DeSimone, Robert W.
    Brittelli, David R.
    Eustice, David C.
    Bourret, Aaron
    Hill-Drzewi, Melissa
    Maciejewski, Patricia M.
    Elkin, Lisa L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (24) : 6991 - 6995
  • [32] Receptor tyrosine kinase, EphB4 (HTK), accelerates differentiation of select human hematopoietic cells.
    Wang, ZY
    Miura, N
    Bonelli, A
    Mole, P
    Carlesso, N
    Scadden, DT
    BLOOD, 2001, 98 (11) : 68A - 68A
  • [33] The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic Target
    Ferguson, Benjamin D.
    Liu, Ren
    Rolle, Cleo E.
    Tan, Yi-Hung Carol
    Krasnoperov, Valery
    Kanteti, Rajani
    Tretiakova, Maria S.
    Cervantes, Gustavo M.
    Hasina, Rifat
    Hseu, Robyn D.
    Iafrate, A. John
    Karrison, Theodore
    Ferguson, Mark K.
    Husain, Aliya N.
    Faoro, Leonardo
    Vokes, Everett E.
    Gill, Parkash S.
    Salgia, Ravi
    PLOS ONE, 2013, 8 (07):
  • [34] EPHB4 RECEPTOR KINASE, A NOVEL THERAPEUTIC TARGET FOR LUNG CANCER
    Gitlitz, Barbara
    Gill, Parkash
    Liu, R.
    Li, Grace
    Liu, Stephen
    Subramanyan, Ram
    El-Khoueiry, Anthony
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S466 - S466
  • [35] Paradoxes of the EphB4 receptor in cancer
    Noren, Nicole K.
    Pasquale, Elena B.
    CANCER RESEARCH, 2007, 67 (09) : 3994 - 3997
  • [36] The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome
    Kumar, S. R.
    Masood, R.
    Spannuth, W. A.
    Singh, J.
    Scehnet, J.
    Kleiber, G.
    Jennings, N.
    Deavers, M.
    Krasnoperov, V.
    Dubeau, L.
    Weaver, F. A.
    Sood, A. K.
    Gill, P. S.
    BRITISH JOURNAL OF CANCER, 2007, 96 (07) : 1083 - 1091
  • [37] Critical Role for the Receptor Tyrosine Kinase EPHB4 in Esophageal Cancers (vol 73, pg 184, 2013)
    Hasina, R.
    Mollberg, N.
    Kawada, I
    Mutreja, K.
    Kanade, G.
    Yala, S.
    CANCER RESEARCH, 2013, 73 (14) : 4594 - 4594
  • [38] The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome
    S R Kumar
    R Masood
    W A Spannuth
    J Singh
    J Scehnet
    G Kleiber
    N Jennings
    M Deavers
    V Krasnoperov
    L Dubeau
    F A Weaver
    A K Sood
    P S Gill
    British Journal of Cancer, 2007, 96 : 1083 - 1091
  • [39] Adult pulmonary vascular remodeling is independent of ephrin-b2/EphB4 guidance system
    Jandl, Katharina
    Klepetko, Walter
    Kwapiszewska, Grazyna
    Marsh, Leigh M.
    Olschewski, Andrea
    Sinn, Katharina
    Zabini, Diana
    Crnkovic, Slaven
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 (19-20) : 512 - 513
  • [40] Targeting the EphB4 receptor tyrosine kinase sensitizes HER2-positive breast cancer cells to Lapatinib
    Ding, Jinlei
    Yao, Yating
    Huang, Gena
    Wang, Xiaonan
    Yi, Jingyan
    Zhang, Nan
    Liu, Chongya
    Wang, Kainan
    Zhang, Yuan
    Wang, Min
    Liu, Pixu
    Ye, Mingliang
    Li, Man
    Cheng, Hailing
    CANCER LETTERS, 2020, 475 : 53 - 64
12345